Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Laboratories (CLB) Cash & Equivalents (2022 - 2025)

Core Laboratories' Cash & Equivalents history spans 4 years, with the latest figure at $22.7 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 18.5% year-over-year to $22.7 million; the TTM value through Dec 2025 reached $22.7 million, up 18.5%, while the annual FY2025 figure was $22.7 million, 18.5% up from the prior year.
  • Cash & Equivalents reached $22.7 million in Q4 2025 per CLB's latest filing, down from $25.6 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $31.2 million in Q2 2025 to a low of $14.9 million in Q1 2024.
  • Average Cash & Equivalents over 4 years is $20.7 million, with a median of $20.3 million recorded in 2024.
  • Peak YoY movement for Cash & Equivalents: tumbled 32.47% in 2024, then surged 76.25% in 2025.
  • A 4-year view of Cash & Equivalents shows it stood at $15.4 million in 2022, then fell by 2.0% to $15.1 million in 2023, then increased by 26.7% to $19.2 million in 2024, then grew by 18.5% to $22.7 million in 2025.
  • Per Business Quant, the three most recent readings for CLB's Cash & Equivalents are $22.7 million (Q4 2025), $25.6 million (Q3 2025), and $31.2 million (Q2 2025).